Ask Us
Please correct the highlighted fields below.

Alerts for Pioglitazone

Title Date Published Source
Neue Anwendungsbeschränkungen und Vorsichtsmaßnahmen für Medikamente mit dem Wirkstoff Pioglitazon 2011-08-01
La AEMPS Alerta De Un Pequeño Riesgo De Cáncer De Vejiga Con Pioglitazona 2011-07-26
TGA Warns of Risk of Bladder Cancer with Pioglitazone 2011-07-25
MHRA Warns Healthcare Professionals about Increased Risk Of Bladder Cancer With Pioglitazone 2011-07-25
La Agencia Española De Medicamentos Y Productos Sanitarios (AEMPS) Anuncia Una Revisión De La Seguridad De La Pioglitazona 2011-07-11
L’AFSSAPS demande la suspension de l’utilisation des médicaments contenant de la pioglitazone (Actos et Competact) en raison d’une faible augmentation du risque de cancer de la vessie 2011-06-18
FDA Issues Safety Update for Ongoing Safety Review of Actos (Pioglitazone) and Increased Risk of Bladder Cancer 2011-06-15
Behörde empfiehlt, Pioglitazon wegen erhöhtem Risiko für Blasenkrebs nicht mehr anzuwenden 2011-06-13
Riesgo De Insuficiencia Cardiaca Con El Uso de Insulina Y Pioglitazona 2011-03-16
Pioglitazone (Actos, Competact) Combined With Insulin Linked To Increased Risk of Heart Failure 2011-03-11
FDA Announces Safety Review of Actos (Pioglitazone) for Cancer Risk 2010-09-17
Thiazolidinediones Associated with Increased Risk of Fractures 2009-06-08
Some Diabetes Drugs to Strengthen Warning on Heart Failure Risk 2007-08-14

See alerts for all drugs